Canadian Cancer Trials Group Bulletins


Canadian Cancer Trials Group Highlighted in New CCS Video

The Canadian Cancer Trials Group is featured in the Canadian Cancer Society's new video entitled "Cancer Research: Living Progress." In particular, Dr. Harriet Richardson speaks specifically about MAP.3, A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer trial, and Dr. Ralph Meyer is also featured in the same chapter titled "Clinical Trials: Putting People in the Process."

In addition, Dr. Kerry Courneya from the University of Alberta is featured in the chapter titled "Life After Cancer: Making Fitness the New Normal". Dr. Courneya is chair of the planned Canadian Cancer Trials Group clinical trial CO.21: A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients with High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial.

Several other Canadian Cancer Trials Group members are also featured describing their own research activities, and include:
  • Dr. Mark Nachtigal who is featured in the chapter titled "Ovarian Cancer: Life Blooms With Daffodils"
  • Dr. Robert Bristow who is featured in the chapter titled "Prostate Cancer: Detecting It Early" (which isn't posted online yet, but should be shortly)
  • Dr. David Huntsman who is featured in the chapter titled "Genetic Screening: A DNA Spellchecker"
  • Dr. Peter Forsyth who is featured in the chapter titled "Finding a Good Virus"

A number of CCS Divisions from across the country have received the DVDs. They will be used for a number of activities, including communication with donors, potential donors, volunteers and staff. It is also being used at the Relay for Life events and leadership/training sessions held across the country.

Most recently it was mentioned in a national ad that appeared in a philanthropy segment in the Globe and Mail.

The video is available on the CCS website at The video is also available by request.